Dataset Information
Metabolomic Profiling Reveals Key Metabolic Alterations in MCF7 Tamoxifen-Resistant Cells Following EPAS1 Inhibition
Ontology highlight
ABSTRACT: This study aims to investigate the metabolic alterations associated with acquired tamoxifen (TAM) resistance in luminal A breast cancer cells. Using untargeted LC-MS/MS metabolomics, we compared parental MCF7 and TAM-resistant MCF7/Tam1 cells to identify key metabolic pathways affected by EPAS1 (HIF-2α)-mediated hypoxia-driven reprogramming. The study further evaluates the impact of EPAS1 inhibition by PT2977 on the reversal of these metabolic changes and restoration of TAM sensitivity.
INSTRUMENT(S): Liquid Chromatography MS -
PROVIDER: MTBLS12677 | MetaboLights | 2025-07-04
REPOSITORIES: MetaboLights
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| MCF7.zip | Other | |||
| MCF7_Tam1.zip | Other | |||
| MCF7_Tam1_PT2977_10uM.zip | Other | |||
| MCF7_Tam1_PT2977_1uM.zip | Other | |||
| a_MTBLS12677_LC-MS___metabolite_profiling.txt | Txt |
Items per page: 1 - 5 of 8 |